{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:50:11Z","timestamp":1793155811891,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.mayocp.2020.06.012","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T15:05:26Z","timestamp":1610031926000},"page":"242-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Polypharmacy Management in Older Patients"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-4977","authenticated-orcid":false,"given":"Robert William","family":"Hoel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Giddings Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1891-309X","authenticated-orcid":false,"given":"Paul Y.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2020.06.012_bib1","volume":"Vol 2019, August 20","author":"Verdier","year":"2013"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejim.2011.08.029","article-title":"Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study","volume":"22","author":"Nobili","year":"2011","journal-title":"Eur J Intern Med"},{"issue":"24","key":"10.1016\/j.mayocp.2020.06.012_bib3","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States","volume":"300","author":"Qato","year":"2008","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.012_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/gerona\/61.5.511","article-title":"Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay","volume":"61","author":"Hanlon","year":"2006","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"10.1016\/j.mayocp.2020.06.012_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/106002809002401114","article-title":"Drug-related problems: their structure and function","volume":"24","author":"Strand","year":"1990","journal-title":"DICP"},{"issue":"10","key":"10.1016\/j.mayocp.2020.06.012_bib6","doi-asserted-by":"crossref","first-page":"e016358","DOI":"10.1136\/bmjopen-2017-016358","article-title":"Association between polypharmacy and falls in older adults: a longitudinal study from England","volume":"7","author":"Dhalwani","year":"2017","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.japh.2017.06.002","article-title":"Association between polypharmacy and death: a systematic review and meta-analysis","volume":"57","author":"Leelakanok","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"7115","key":"10.1016\/j.mayocp.2020.06.012_bib8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","article-title":"Optimising drug treatment for elderly people: the prescribing cascade","volume":"315","author":"Rochon","year":"1997","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.mayocp.2020.06.012_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4140\/TCP.n.2018.562.","article-title":"Polypharmacy and adherence among diabetic patients in Greece","volume":"33","author":"Geitona","year":"2018","journal-title":"Consult Pharm"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.012_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.012_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/PTS.0000000000000067","article-title":"Predicting potential postdischarge adverse drug events and 30-day unplanned hospital readmissions from medication regimen complexity","volume":"10","author":"Schoonover","year":"2014","journal-title":"J\u00a0Patient Saf"},{"key":"10.1016\/j.mayocp.2020.06.012_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/CIA.S94126","article-title":"Physicians' use of computerized clinical decision supports to improve medication management in the elderly: the Seniors Medication Alert and Review Technology intervention","volume":"11","author":"Alagiakrishnan","year":"2016","journal-title":"Clin Interv Aging"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.012_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.amjopharm.2007.10.001","article-title":"Pharmacodynamics in older adults: a review","volume":"5","author":"Bowie","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.012_bib14","doi-asserted-by":"crossref","first-page":"e000281","DOI":"10.1136\/bmjoq-2017-000281","article-title":"Improving medication reconciliation at hospital admission, discharge and ambulatory care through a transition of care team","volume":"7","author":"Kreckman","year":"2018","journal-title":"BMJ Open Qual"},{"issue":"7","key":"10.1016\/j.mayocp.2020.06.012_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4140\/TCP.n.2019.456","article-title":"Impact of the pharmacists' patient care process on medication adherence in older adults with multimorbidity","volume":"34","author":"Whittaker","year":"2019","journal-title":"Sr Care Pharm"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jash.2015.04.004","article-title":"Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension","volume":"9","author":"Pandey","year":"2015","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"11","key":"10.1016\/j.mayocp.2020.06.012_bib17","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.012_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CPP46072","article-title":"STOPP (Screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment): consensus validation","volume":"46","author":"Gallagher","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.mayocp.2020.06.012_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3928\/00989134-20090731-01","article-title":"Psychotropic medication use among older adults: what all nurses need to know","volume":"35","author":"Lindsey","year":"2009","journal-title":"J\u00a0Gerontol Nurs"},{"key":"10.1016\/j.mayocp.2020.06.012_bib20","series-title":"Medication Overload: America's Other Drug Problem","author":"Garber","year":"2019"},{"issue":"12","key":"10.1016\/j.mayocp.2020.06.012_bib21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjmed.2009.02.021","article-title":"Drug burden index score and functional decline in older people","volume":"122","author":"Hilmer","year":"2009","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.012_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.mayocp.2020.06.012_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatr"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2020.06.012_bib24","first-page":"142","article-title":"The 2012 update to the anticholinergic cognitive burden scale","volume":"61","author":"Campbell","year":"2013","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"21","key":"10.1016\/j.mayocp.2020.06.012_bib25","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocp.2020.06.012_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jdiacomp.2017.02.014","article-title":"Liberating A1C goals in older adults may not protect against the risk of hypoglycemia","volume":"31","author":"Munshi","year":"2017","journal-title":"J\u00a0Diabetes Complications"},{"issue":"8","key":"10.1016\/j.mayocp.2020.06.012_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40266-019-00683-8","article-title":"Going beyond the guidelines in individualising the use of antihypertensive drugs in older patients","volume":"36","author":"Scott","year":"2019","journal-title":"Drugs Aging"},{"issue":"43","key":"10.1016\/j.mayocp.2020.06.012_bib28","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1093\/eurheartj\/ehz458","article-title":"Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France","volume":"40","author":"Giral","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.mayocp.2020.06.012_bib29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.7326\/0003-4819-159-12-201312170-00011","article-title":"Enough is enough: stop wasting money on vitamin and mineral supplements","volume":"159","author":"Guallar","year":"2013","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mayocp.2020.06.012_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.7326\/0003-4819-159-12-201312170-00729","article-title":"Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the US Preventive Services Task Force","volume":"159","author":"Fortmann","year":"2013","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.012_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cger.2017.01.004","article-title":"The role of patient preferences in deprescribing","volume":"33","author":"Holmes","year":"2017","journal-title":"Clin Geriatr Med"},{"issue":"11","key":"10.1016\/j.mayocp.2020.06.012_bib32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881113503509","article-title":"Benzodiazepines: risks and benefits: a reconsideration","volume":"27","author":"Baldwin","year":"2013","journal-title":"J\u00a0Psychopharmacol"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.012_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/clpt.2008.211","article-title":"Rational prescribing for patients with a reduced life expectancy","volume":"85","author":"Holmes","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"3 suppl 1","key":"10.1016\/j.mayocp.2020.06.012_bib34","first-page":"S12","article-title":"Management of pain in older adults","volume":"105","author":"Cavalieri","year":"2005","journal-title":"J\u00a0Am Osteopath Assoc"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib35","first-page":"514","article-title":"Is the WHO analgesic ladder still valid? Twenty-four years of experience","volume":"56","author":"Vargas-Schaffer","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.mayocp.2020.06.012_bib36","first-page":"515","article-title":"Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review","volume":"9","author":"Carlson","year":"2016","journal-title":"J\u00a0Pain Res"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.012_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain: United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.012_bib38","first-page":"26","article-title":"Special considerations for opioid use in elderly patients with chronic pain","volume":"43","author":"Wu","year":"2018","journal-title":"US Pharm"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib39","first-page":"CD007402","article-title":"Topical NSAIDs for acute musculoskeletal pain in adults","author":"Derry","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.mayocp.2020.06.012_bib40","first-page":"CD007407","article-title":"Psychological therapies for the management of chronic pain (excluding headache) in adults","author":"Williams","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.012_bib41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.012_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1745-7599.2008.00311.x","article-title":"Clinical practice algorithms: medication management to reduce fall risk in the elderly-part 4, anticoagulants, anticonvulsants, anticholinergics\/bladder relaxants, and antipsychotics","volume":"20","author":"Bulat","year":"2008","journal-title":"J\u00a0Am Acad Nurse Pract"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.012_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1745-7599.2007.00285.x","article-title":"Clinical practice algorithms: medication management to reduce fall risk in the elderly-part 3, benzodiazepines, cardiovascular agents, and antidepressants","volume":"20","author":"Bulat","year":"2008","journal-title":"J\u00a0Am Acad Nurse Pract"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.012_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1745-7599.2007.00272.x","article-title":"Clinical practice algorithms: medication management to reduce fall risk in the elderly-part 2, summary algorithm","volume":"20","author":"Bulat","year":"2008","journal-title":"J\u00a0Am Acad Nurse Pract"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.012_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1440-172X.2005.00510.x","article-title":"Physical and chemical restraints in acute care: their potential impact on the rehabilitation of older people","volume":"11","author":"Mott","year":"2005","journal-title":"Int J Nurs Pract"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.012_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1440-0979.2003.00265.x","article-title":"Improving geriatric mental health nursing care: making a case for going beyond psychotropic medications","volume":"12","author":"Voyer","year":"2003","journal-title":"Int J Ment Health Nurs"},{"key":"10.1016\/j.mayocp.2020.06.012_bib47","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.mayocp.2020.06.012_bib48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","article-title":"The relationship between benzodiazepine use and traffic accidents: a systematic literature review","volume":"24","author":"Smink","year":"2010","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.012_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/14740338.3.5.485","article-title":"Safety of benzodiazepines in the geriatric population","volume":"3","author":"Madhusoodanan","year":"2004","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.012_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/ajp.148.2.151","article-title":"The APA Task Force report on benzodiazepine dependence, toxicity, and abuse","volume":"148","author":"Salzman","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"20","key":"10.1016\/j.mayocp.2020.06.012_bib51","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2017.15683","article-title":"Clinical management of insomnia disorder","volume":"318","author":"Buysse","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.012_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2017.6996","article-title":"Treating anxiety in 2017: optimizing care to improve outcomes","volume":"318","author":"Stein","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00131746-200111000-00003","article-title":"Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines","volume":"7","author":"Alexopoulos","year":"2001","journal-title":"J\u00a0Psychiatr Pract"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib54","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.mayocp.2020.06.012_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/2042098618816562","article-title":"The impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study","volume":"10","author":"Gnjidic","year":"2019","journal-title":"Ther Adv Drug Saf"},{"issue":"590","key":"10.1016\/j.mayocp.2020.06.012_bib56","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.3399\/bjgp11X593857","article-title":"Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis","volume":"61","author":"Mugunthan","year":"2011","journal-title":"Br J Gen Pract"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2020.06.012_bib57","first-page":"5","article-title":"Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. Using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.mayocp.2020.06.012_bib58","series-title":"Deaths with antipsychotics in elderly patients with behavioral disturbances","volume":"Vol 2019","year":"2011"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.012_bib59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0973-1229.58818","article-title":"The geriatric population and psychiatric medication","volume":"8","author":"Varma","year":"2010","journal-title":"Mens Sana Monogr"},{"issue":"8","key":"10.1016\/j.mayocp.2020.06.012_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/02793695-20100708-01","article-title":"Potential adverse effects of discontinuing psychotropic drugs. Part 3: antipsychotic, dopaminergic, and mood-stabilizing drugs","volume":"48","author":"Howland","year":"2010","journal-title":"J\u00a0Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.mayocp.2020.06.012_bib61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.psychres.2018.10.001","article-title":"Attempting to discontinue antipsychotic medication: withdrawal methods, relapse and success","volume":"270","author":"Larsen-Barr","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.mayocp.2020.06.012_bib62","series-title":"Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients, and Their Families","author":"Breggin","year":"2013"},{"key":"10.1016\/j.mayocp.2020.06.012_bib63","series-title":"Harm Reduction Guide to Coming Off Psychiatric Drugs","author":"Hall","year":"2012"},{"issue":"12","key":"10.1016\/j.mayocp.2020.06.012_bib64","first-page":"CD008634","article-title":"Psychosocial interventions for reducing antipsychotic medication in care home residents","author":"Richter","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.012_bib65","first-page":"414","article-title":"Are atypical antipsychotics safe in patients with Alzheimer's disease?","volume":"74","author":"Jones","year":"2006","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.012_bib66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3949\/ccjm.85a.16080","article-title":"Alzheimer dementia: starting, stopping drug therapy","volume":"85","author":"Kim","year":"2018","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2015.03.003","article-title":"Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review","volume":"16","author":"Jokanovic","year":"2015","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.012_bib68","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/1874609809999160217101716","article-title":"Assessing medication problems in those >\/= 65 using the STOPP and START criteria","volume":"9","author":"Thomas","year":"2016","journal-title":"Curr Aging Sci"},{"key":"10.1016\/j.mayocp.2020.06.012_bib69","volume":"Vol 2019","year":"2017"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.012_bib70","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jamda.2018.10.026","article-title":"Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis","volume":"20","author":"Kua","year":"2019","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.012_bib71","doi-asserted-by":"crossref","first-page":"e015293","DOI":"10.1136\/bmjopen-2016-015293","article-title":"Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol","volume":"7","author":"Kua","year":"2017","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.mayocp.2020.06.012_bib72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/dc15-2512","article-title":"Management of diabetes in long-term care and skilled nursing facilities: a position statement of the American Diabetes Association","volume":"39","author":"Munshi","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mayocp.2020.06.012_bib73","article-title":"Examination of the new short-stay nursing home quality measures: rehospitalizations, emergency department visits, and successful returns to the community","volume":"55","author":"Saliba","year":"2018","journal-title":"Inquiry"},{"issue":"5","key":"10.1016\/j.mayocp.2020.06.012_bib74","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1176\/appi.ajp.2015.173501","article-title":"The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia","volume":"173","author":"Reus","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.mayocp.2020.06.012_bib75","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.2017.11112","article-title":"Antipsychotics to treat agitation or psychosis in patients with dementia","volume":"318","author":"Yohanna","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.012_bib76","first-page":"17","article-title":"Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline","volume":"64","author":"Bjerre","year":"2018","journal-title":"Can Fam Physician"},{"issue":"3","key":"10.1016\/j.mayocp.2020.06.012_bib77","first-page":"CD007726","article-title":"Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia","author":"Van Leeuwen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.012_bib78","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0050076","article-title":"A\u00a0randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)","volume":"5","author":"Ballard","year":"2008","journal-title":"PLoS Med"},{"issue":"16","key":"10.1016\/j.mayocp.2020.06.012_bib79","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1114058","article-title":"Relapse risk after discontinuation of risperidone in Alzheimer's disease","volume":"367","author":"Devanand","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2020.06.012_bib80","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jamda.2018.06.023","article-title":"Discontinuation of long-term antipsychotic drug use for behavioral and psychological symptoms in older adults aged 65 years and older with dementia","volume":"19","author":"Van Leeuwen","year":"2018","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.mayocp.2020.06.012_bib81","doi-asserted-by":"crossref","first-page":"e0122246","DOI":"10.1371\/journal.pone.0122246","article-title":"What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process","volume":"10","author":"Farrell","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.mayocp.2020.06.012_bib82","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","article-title":"A\u00a0systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people","volume":"73","author":"Reeve","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.mayocp.2020.06.012_bib83","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/14740338.2014.925444","article-title":"Risk versus risk: a review of benzodiazepine reduction in older adults","volume":"13","author":"Paquin","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2020.06.012_bib84","first-page":"A251","article-title":"PS-055 Benzodiazepines and z-drugs deprescription by a multidisciplinary pharmacotherapy revision focused on the patient (abstract)","volume":"24","author":"Ortonobes Roig","year":"2017","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"10.1016\/j.mayocp.2020.06.012_bib85","doi-asserted-by":"crossref","first-page":"83.e9","DOI":"10.1016\/j.jamda.2011.02.009","article-title":"Inappropriate drug prescription at nursing home admission","volume":"13","author":"Garcia-Gollarte","year":"2012","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.mayocp.2020.06.012_bib86","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.sapharm.2016.11.012","article-title":"A\u00a0novel approach to deprescribing in long-term care settings: the SMART campaign","volume":"13","author":"Abrahamson","year":"2017","journal-title":"Res Social Adm Pharm"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620306169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620306169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:33:55Z","timestamp":1758418435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620306169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0025619620306169"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.012","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypharmacy Management in Older Patients","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}